Teva Pharmaceutical Industries Limited

TEVAReported Nov 3 · Q3 2026
$40.70−$1.39 −3.30%At close · November 2
Price1Y range $20.46 – $42.09

Estimation history is only available for connected users.

vs. 4-yr trend
RATIO TREND TTM
Free Cash Flow Ratiosgreen ≥ 5%
'23 → 2025
—
Net Income Margin Ratiosgreen ≥ 15%
'23 → 2025
—
Return on Equity Ratiosgreen ≥ 15%
'23 → 2025
—
Return on Asset Ratiosgreen ≥ 7%
'23 → 2025
—
Total Revenue YoY Growth 4.13%
Cash from Ops YoY Growth 36.55%
Your TEVA research, in one place

Sign in to keep private notes and post comments other investors can read.

Sign In
An unhandled error has occurred. Reload 🗙